HighMark Wealth Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-580
| Closed | -$1.57K | – | 634 |
|
|
2023
Q1 | $1.57K | Hold |
580
| – | – | ﹤0.01% | 520 |
|
|
2022
Q4 | $2.31K | Sell |
580
-1
| -0.2% | -$4 | ﹤0.01% | 421 |
|
|
2022
Q3 | $4K | Hold |
581
| – | – | ﹤0.01% | 382 |
|
|
2022
Q2 | $7K | Hold |
581
| – | – | 0.01% | 312 |
|
|
2022
Q1 | $10K | Hold |
581
| – | – | 0.01% | 274 |
|
|
2021
Q4 | $38K | Hold |
581
| – | – | 0.02% | 137 |
|
|
2021
Q3 | $40K | Hold |
581
| – | – | 0.03% | 131 |
|
|
2021
Q2 | $40K | Hold |
581
| – | – | 0.03% | 133 |
|
|
2021
Q1 | $38K | Buy |
581
+25
| +4% | +$1.64K | 0.03% | 121 |
|
|
2020
Q4 | $32K | Buy |
556
+112
| +25% | +$6.45K | 0.03% | 130 |
|
|
2020
Q3 | $26K | Buy |
444
+166
| +60% | +$9.72K | 0.02% | 146 |
|
|
2020
Q2 | $36K | Buy |
278
+56
| +25% | +$7.25K | 0.04% | 92 |
|
|
2020
Q1 | $13K | Sell |
222
-845
| -79% | -$49.5K | 0.02% | 141 |
|
|
2019
Q4 | $134K | Buy |
+1,067
| New | +$134K | 0.14% | 47 |
|